Professional Seasonal Analysis for Trading

Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)

Seasonality Analysis

Stocks 13 Years Analyzed

Ultragenyx Pharmaceutical Inc. - Common Stock Annual Seasonality Statistics

0.73%
Avg Annual Return
45.0%
Avg Monthly Win Rate
8/12
Positive Months
13
Years Analyzed

Ultragenyx Pharmaceutical Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 1.50%
67%
Strong
February BEST 5.71%
38%
Weak
March WORST -7.88%
31%
Very Weak
April 1.23%
46%
Weak
May 2.23%
42%
Weak
June 5.44%
67%
Strong
July -2.47%
42%
Weak
August 3.77%
58%
Moderate
September -5.61%
17%
Very Weak
October -6.32%
33%
Very Weak
November 1.81%
42%
Weak
December 1.33%
58%
Moderate

Ultragenyx Pharmaceutical Inc. - Common Stock 2026 vs Historical Pattern

Current Position
100
Historical Avg Position
47.49
Deviation
+52.51
Performance
Significantly Above Average

Ultragenyx Pharmaceutical Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for RARE with overlay patterns, custom date ranges, and more.

Create Free Account

Ultragenyx Pharmaceutical Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Ultragenyx Pharmaceutical Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for RARE across multiple timeframes.

Create Free Account

About Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) Seasonality

Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) has been analyzed using 13 years of historical data to identify seasonal patterns. Classified under Stocks, Ultragenyx Pharmaceutical Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Ultragenyx Pharmaceutical Inc. - Common Stock is historically February, with an average return of 5.71% and a win rate of 38%. Conversely, March tends to be the weakest month, averaging -7.88% return.

Looking at the full calendar year, Ultragenyx Pharmaceutical Inc. - Common Stock has an average annual return of 0.73% with an overall monthly win rate of 45.0%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Ultragenyx Pharmaceutical Inc. - Common Stock has a consistency score of 42.2 (Poor), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Ultragenyx Pharmaceutical Inc. - Common Stock Seasonality FAQ

What is the best month to buy Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)?

Historically, February has been the best month for Ultragenyx Pharmaceutical Inc. - Common Stock, with an average return of 5.71% and a win rate of 38%. However, past performance does not guarantee future results.

What is the worst month for Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)?

Based on historical data, March has been the weakest month for Ultragenyx Pharmaceutical Inc. - Common Stock, with an average return of -7.88%. This is a historical observation and does not guarantee future results.

How reliable is RARE seasonality data?

The seasonality analysis for Ultragenyx Pharmaceutical Inc. - Common Stock is based on 13 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Ultragenyx Pharmaceutical Inc. - Common Stock seasonality in my trading?

Use Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.